| iShares Core S&P 500 ETF | 1 092 266 | 713,5 M $ | |
| iShares Core U.S. Aggregate Bond ETF | 4 100 066 | 407 M $ | |
| Simplify Exchange Traded Funds | 5 528 700 | 116,7 M $ | |
| Simplify Exchange Traded Funds | 1 634 812 | 72,2 M $ | |
| Simplify Exchange Traded Funds | 3 777 620 | 45,8 M $ | |
| Simplify Exchange Traded Funds | 2 109 127 | 42,9 M $ | |
| Simplify Exchange Traded Funds | 1 700 000 | 40 M $ | |
| Simplify Exchange Traded Funds | 1 553 376 | 37,5 M $ | |
| Plains GP Holdings LP | 1 272 360 | 30,9 M $ | |
| iShares Bitcoin Trust ETF | 700 000 | 26,9 M $ | |
| Simplify Exchange Traded Funds | 822 303 | 24,4 M $ | |
| United Therapeutics Corp | 34 251 | 20,3 M $ | |
| Align Technology Inc | 106 897 | 18,3 M $ | |
| Eli Lilly & Co | 16 703 | 15,4 M $ | |
| Simplify Exchange Traded Funds | 624 406 | 14,7 M $ | |
| Novo Nordisk A/S | 327 357 | 12 M $ | |
| AbbVie Inc | 48 621 | 10,6 M $ | |
| PureCycle Technologies Inc | 1 770 778 | 9,2 M $ | |
| Thermo Fisher Scientific Inc | 17 409 | 8,6 M $ | |
| Gilead Sciences Inc | 61 345 | 8,5 M $ | |
| Regeneron Pharmaceuticals, Inc. | 10 900 | 8,4 M $ | |
| Johnson & Johnson | 33 121 | 8,1 M $ | |
| 10X Genomics Inc | 354 703 | 7,5 M $ | |
| 3M Co | 44 241 | 6,4 M $ | |
| Warby Parker Inc | 290 831 | 6,1 M $ | |
| Danaher Corp | 32 304 | 6,1 M $ | |
| Benitec Biopharma Inc | 562 242 | 6 M $ | |
| Amgen Inc | 15 844 | 5,6 M $ | |
| Intuitive Surgical Inc | 10 767 | 5 M $ | |
| Simplify Exchange Traded Funds | 151 381 | 4,6 M $ | |
| EyePoint Inc | 326 142 | 4,2 M $ | |
| Tesla Inc | 11 094 | 4,1 M $ | |
| VanEck Bitcoin ETF/US | 209 151 | 4 M $ | |
| CVS Health Corp | 54 013 | 3,9 M $ | |
| Vertex Pharmaceuticals Inc | 7 936 | 3,5 M $ | |
| ACHIEVE LIFE SCIENCES INC | 1 184 512 | 3,5 M $ | |
| Alignment Healthcare Inc | 193 032 | 3,4 M $ | |
| Rithm Capital Corp | 336 593 | 3,2 M $ | |
| Phathom Pharmaceuticals Inc | 262 386 | 2,9 M $ | |
| Simplify Exchange Traded Funds | 125 000 | 2,8 M $ | |
| GE HealthCare Technologies Inc | 39 260 | 2,8 M $ | |
| Simplify Exchange Traded Funds | 100 000 | 2,7 M $ | |
| Simplify Exchange Traded Funds | 91 464 | 2,6 M $ | |
| Delcath Systems Inc | 261 126 | 2,4 M $ | |
| Abeona Therapeutics Inc | 507 988 | 2,3 M $ | |
| Celldex Therapeutics Inc | 68 994 | 2,2 M $ | |
| MFA Financial Inc | 209 000 | 2 M $ | |
| Guardant Health Inc | 20 821 | 1,9 M $ | |
| Walmart Inc | 14 217 | 1,8 M $ | |
| Insmed Inc | 10 783 | 1,8 M $ | |
| Palantir Technologies Inc | 11 704 | 1,7 M $ | |
| Abbott Laboratories | 15 506 | 1,6 M $ | |
| Cisco Systems, Inc. | 19 859 | 1,5 M $ | |
| LeonaBio Inc | 149 279 | 1,5 M $ | |
| Corcept Therapeutics Inc | 37 763 | 1,5 M $ | |
| Kyverna Therapeutics Inc | 173 106 | 1,5 M $ | |
| Pacira BioSciences Inc | 62 653 | 1,4 M $ | |
| Inventiva SACA | 227 923 | 1,3 M $ | |
| Berkshire Hathaway Inc | 2 622 | 1,3 M $ | |
| International Business Machines Corp. | 4 790 | 1,2 M $ | |
| Edwards Lifesciences Corp | 14 078 | 1,1 M $ | |
| Viridian Therapeutics Inc | 56 231 | 1,1 M $ | |
| Annaly Capital Management Inc | 49 403 | 1 M $ | |
| Dynex Capital Inc | 81 579 | 1 M $ | |
| AGNC Investment Corp | 103 485 | 1 M $ | |
| Oxford Lane Capital Corp | 100 000 | 978 k $ | |
| Aquestive Therapeutics Inc | 234 279 | 972,3 k $ | |
| Vor BioPharma Inc | 53 510 | 954,6 k $ | |
| Zevra Therapeutics Inc | 100 630 | 937,9 k $ | |
| Orchestra BioMed Holdings Inc | 219 387 | 932,4 k $ | |
| ARMOUR Residential REIT Inc | 53 900 | 899,1 k $ | |
| Fulcrum Therapeutics Inc | 115 994 | 889,7 k $ | |
| Compass Pathways plc | 159 052 | 879,6 k $ | |
| Exxon Mobil Corp | 4 871 | 826,4 k $ | |
| Merck & Co Inc | 6 544 | 787,2 k $ | |
| UnitedHealth Group Inc | 2 901 | 785 k $ | |
| Trevi Therapeutics Inc | 65 412 | 780,4 k $ | |
| Mastercard Inc | 1 526 | 762,5 k $ | |
| Ocular Therapeutix Inc | 90 000 | 762,3 k $ | |
| QUALCOMM Inc | 5 574 | 717,8 k $ | |
| SAB Biotherapeutics Inc | 187 230 | 717,1 k $ | |
| Cooper Cos Inc/The | 9 942 | 710,9 k $ | |
| Boston Scientific Corp | 11 324 | 710,6 k $ | |
| Upstream Bio Inc | 77 793 | 700,1 k $ | |
| 4D Molecular Therapeutics Inc | 70 430 | 655,7 k $ | |
| Chimera Investment Corp | 51 025 | 640,4 k $ | |
| Palo Alto Networks Inc | 3 967 | 636 k $ | |
| Palisade Bio Inc | 350 000 | 612,5 k $ | |
| Intuit Inc | 1 416 | 612,3 k $ | |
| ServiceNow Inc | 5 421 | 566,8 k $ | |
| Stryker Corp | 1 710 | 561,9 k $ | |
| Adobe Inc | 2 266 | 550,8 k $ | |
| TG Therapeutics Inc | 16 049 | 533,1 k $ | |
| Comcast Corp | 18 691 | 524,3 k $ | |
| KALARIS THERAPEUTICS INC | 87 426 | 504,4 k $ | |
| Dell Technologies Inc | 3 073 | 504,4 k $ | |
| IMMUNIC INC | 438 932 | 487,2 k $ | |
| General Electric Co | 1 667 | 473 k $ | |
| Coherus Oncology Inc | 253 140 | 427,8 k $ | |
| Western Digital Corp | 1 533 | 414,7 k $ | |